CNS Pharmaceuticals Inc (CNSP) — Defensive Interval Ratio
CNS Pharmaceuticals Inc (CNSP) has a Defensive Interval Ratio of 0 days as of December 2025. Defensive assets of $0.00 (cash $-, short-term investments $-, receivables $0.00) cover 0 days of daily cash needs of $11.24K/day. See CNSP current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
CNS Pharmaceuticals Inc Defensive Interval Ratio (2023–2025)
This chart shows how CNS Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 3 annual periods from 2023 to 2025. As of December 2025, the ratio stands at 0 days, meaning defensive assets of $0.00 can fund 0 days of operations without new revenue. See CNS Pharmaceuticals Inc net asset quality index to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for CNS Pharmaceuticals Inc (2023–2025)
The table below presents the year-by-year Defensive Interval Ratio for CNS Pharmaceuticals Inc from 2023 to 2025, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market value of CNS Pharmaceuticals Inc.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 0 days | $0.00 | $11.24K/day | $- | $- | ▼ -128 days |
| 2024 | 128 days | $882.54K | $6.92K/day | $- | $- | ▲ +128 days |
| 2023 | 0 days | $0.00 | $16.80K/day | $- | $- | — |